MedWatch

Latest news

Filters

Danish websites

English websites

TIME

Select / Deselect all
Date Article Site
08:15 Ambu, Coloplast and GN helped by relaxation of China's covid policy medwatch (en)
07:22 Sonova completes Hysound Group acquisition, strengthens presence in China medwatch (en)
02/12 Top news from MedWatch this week medwatch (en)
02/12 Extra data boosts Lundbeck's agitation case medwatch (en)
02/12 Acquisitions to help Coloplast attain growth goal medwatch (en)
02/12 Coloplast conducts catheter study to highlight single-use benefits medwatch (en)
02/12 FDA confirms rejection of Y-mabs' cancer drug medwatch (en)
02/12 Novo reaches share milestone, analyst credits Wegovy medwatch (en)
01/12 FDA approves Ferring microbiotica-based treatment medwatch (en)
01/12 Analyst spies alternative buyers in the wings as Cochlear's potential Oticon acquisition raises eyebrows medwatch (en)
01/12 Analyst proposes four solutions as GN battles with ghosts of debts past medwatch (en)
01/12 Former US head of Leo Pharma gets board seat at Kempharm medwatch (en)
01/12 Novo Nordisk to test best-selling substance in stroke indication medwatch (en)
01/12 ALK CFO to step down medwatch (en)
01/12 Potential Demant divestment raises competition concerns medwatch (en)
01/12 Pharmacosmos tight-lipped on competitor's Chinese market nod medwatch (en)
30/11 UK authority warns of Dupixent adverse effects medwatch (en)
30/11 Patient Square Capital becomes majority owner of Eargo medwatch (en)
30/11 Retention, retention, retention – Danish life science firms shower employees in extra benefits medwatch (en)
30/11 Horizon confirms buyer interest from Amgen, Janssen, Sanofi medwatch (en)
30/11 Eisai and Biogen's Alzheimer’s drug sparks hot debate over benefits as risks like brain bleeding emerge medwatch (en)
30/11 Novo Nordisk moves digital unit, appoints new head medwatch (en)
29/11 FDA response to Novo supplier eliminates some Wegovy supply concerns medwatch (en)
29/11 Axsome races for Alzheimer's agitation approval medwatch (en)
29/11 Bank counts on double-digit growth for Novo Nordisk in 2023 medwatch (en)
29/11 China approves Vifor's iron deficiency IV infusion medwatch (en)
29/11 Ambu raises prices, drops discounts, and hopes for customer understanding medwatch (en)
29/11 Eisai and Biogen plunge after report of second death in groundbreaking Alzheimer’s drug trial medwatch (en)
29/11 WS Audiology cautious about new hires – but has no layoff plans medwatch (en)
28/11 WS Audiology CEO expects market slowdown to continue in coming months medwatch (en)
28/11 WSA CEO says Kirkland Signature absence at Costco has helped medwatch (en)
28/11 FDA green-lights Diamyd Medical's paused diabetes vaccine study medwatch (en)
28/11 Bank believes in cancer approval for Genmab medwatch (en)
28/11 Bavarian Nordic grants all employees an extra four days off medwatch (en)
28/11 WS Audiology lives up to topline growth expectations – sees challenges ahead medwatch (en)
25/11 Top news from MedWatch this week medwatch (en)
25/11 Danish reimbursement committee submits diabetes reassessment proposal for feedback medwatch (en)
25/11 Ambu exits Russia medwatch (en)
25/11 Denmark rejects Gilead and Eisai cancer drugs medwatch (en)
25/11 Central Norwegian bank's stake in GN Group drops below 5% medwatch (en)
25/11 Bavarian Nordic chair sells shares for USD 100,000 medwatch (en)
24/11 Ambu retires main argument for single-use endoscopes medwatch (en)
24/11 Denmark recommends Lundbeck migraine treatment medwatch (en)
24/11 WSA and Philips raise prices after discount ends at Costco medwatch (en)
24/11 Fujifilm to build USD 188m manufacturing facility in US medwatch (en)
24/11 Analysts agree: Kåre Schultz was the right man for Teva – for a time medwatch (en)
24/11 Analyst spots a future for Sonova at Costo medwatch (en)
24/11 Genmab's chief development officer sells shares in US medwatch (en)
23/11 GN Hearing CFO finds new job medwatch (en)
23/11 Strained Danish job market poses challenge for Novo's newest expansion medwatch (en)
1 - 50 of 3107